Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.00081 | 1 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.00079 | 1 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.0034 | 1 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.00062 | 1 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |